Your browser doesn't support javascript.
loading
No Changes in Keratometry Readings and Anterior Chamber Depth after XEN Gel Implantation in Patients with Glaucoma.
Tatti, Filippo; Tronci, Claudia; Lixi, Filippo; Demarinis, Giuseppe; Kuzmich, Sviatlana; Peiretti, Enrico; Fossarello, Maurizio; Giannaccare, Giuseppe.
Afiliación
  • Tatti F; Department of Surgical Sciences, Eye Clinic, University of Cagliari, 09124 Cagliari, Italy.
  • Tronci C; Department of Surgical Sciences, Eye Clinic, University of Cagliari, 09124 Cagliari, Italy.
  • Lixi F; Department of Surgical Sciences, Eye Clinic, University of Cagliari, 09124 Cagliari, Italy.
  • Demarinis G; Department of Surgical Sciences, Eye Clinic, University of Cagliari, 09124 Cagliari, Italy.
  • Kuzmich S; Department of Surgical Sciences, Eye Clinic, University of Cagliari, 09124 Cagliari, Italy.
  • Peiretti E; Department of Surgical Sciences, Eye Clinic, University of Cagliari, 09124 Cagliari, Italy.
  • Fossarello M; Department of Surgical Sciences, Eye Clinic, University of Cagliari, 09124 Cagliari, Italy.
  • Giannaccare G; Department of Surgical Sciences, Eye Clinic, University of Cagliari, 09124 Cagliari, Italy.
J Clin Med ; 13(9)2024 Apr 26.
Article en En | MEDLINE | ID: mdl-38731065
ABSTRACT

Background:

This study aimed to compare keratometry and anterior chamber depth (ACD) changes after XEN implantation in primary open-angle glaucoma (POAG) cases over a 3-month follow-up period.

Methods:

Twenty patients with POAG who underwent XEN63 implantation, either standalone or combined with cataract surgery, were included. Preoperative data, including best-corrected visual acuity (BCVA), refraction, gonioscopy, ophthalmoscopy, intraocular pressure (IOP) evaluation, and axial length, were collected. Corneal topography and ACD measurements were assessed preoperatively and at postoperative days 1, 7, 15, 30, 60, and 90. Each patient's eye that underwent XEN surgery was included in the study group, with the fellow eye serving as a control.

Results:

In the study group, there was a significant decrease in IOP after XEN stent implantation at all investigated time intervals (p < 0.05). However, changes in mean ACD did not show statistically significant differences at any follow-up examination in both the study and control groups. Additionally, keratometry readings revealed no significant changes in total astigmatism or steep keratometry values in either group.

Conclusions:

XEN implantation in POAG cases resulted in a significant decrease in IOP over the 3-month follow-up period. However, there were no significant changes observed in mean ACD or keratometry readings, indicating stability in these parameters post-XEN implantation. These findings suggest that XEN implantation may be an effective option for IOP reduction without affecting corneal curvature or ACD in POAG patients.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Clin Med Año: 2024 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Clin Med Año: 2024 Tipo del documento: Article País de afiliación: Italia